Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: New analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE) / Smolen, Josef S.; Wollenhaupt, Jürgen; Gomez-Reino, Juan J.; Grassi, Walter; Gaillez, Corine; Poncet, Coralie; Le Bars, Manuela; Westhovens, Rene. - In: ARTHRITIS RESEARCH & THERAPY. - ISSN 1478-6354. - 17:1(2015), p. 157. [10.1186/s13075-015-0671-9]
Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: New analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE)
Grassi, Walter;
2015-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
